Warehoused and Written Off: How Private Equity Turned America's Nursing Homes Into Profit Centers and Left Elders to Pay the Price

The Business Model Behind the Bedsores

In 2021, a landmark study published in the Journal of the American Medical Association found that nursing homes acquired by private equity firms experienced a 10 percent increase in short-term mortality among Medicare patients compared with facilities under other ownership models. Residents in private equity-owned homes were more likely to develop pressure ulcers, experience falls, and receive antipsychotic medications as a chemical substitute for adequate staff attention. These are not abstract statistics. They represent human beings — someone's grandmother, someone's father — whose final years were shaped in part by the investment thesis of a fund manager they never met.

Private equity's entry into long-term care began in earnest in the early 2000s and accelerated through the 2010s. Firms including The Carlyle Group, Warburg Pincus, and Formation Capital assembled portfolios of nursing home chains, applying to elder care the same financial engineering playbook used in retail, media, and manufacturing: acquire with leveraged debt, extract value through sale-leaseback arrangements on real estate, reduce labor costs aggressively, and exit within a three-to-seven-year window before the consequences of underinvestment become fully visible.

By 2020, private equity-affiliated entities owned or operated an estimated 1,500 to 2,000 nursing facilities across the United States, according to research from the University of Pennsylvania's Wharton School. The COVID-19 pandemic made the stakes of this ownership model impossible to ignore: nursing homes became the site of more than 150,000 deaths in the pandemic's first two years, and facilities with inadequate staffing — a defining feature of private equity ownership — suffered disproportionately.

The Mechanics of Extraction

To understand why private equity ownership correlates with worse outcomes, it helps to understand how the financial engineering actually works. When a private equity firm acquires a nursing home chain, it typically does so using a significant portion of borrowed money, the debt for which is loaded onto the acquired company rather than the acquiring fund. This immediately increases the financial pressure on the facility to generate cash — pressure that is resolved, in the absence of revenue growth, by cutting costs.

In a nursing home, the dominant cost is labor. Registered nurses, certified nursing assistants, and ancillary staff represent the overwhelming majority of operating expenses. When a fund's financial model demands margin expansion, the first target is staffing ratios. The results are predictable: fewer nurses per resident, more reliance on less-trained and lower-paid aides, higher turnover as working conditions deteriorate, and a facility that is chronically stretched beyond its capacity to provide safe care.

The sale-leaseback mechanism adds a second layer of extraction. Private equity owners frequently sell a facility's physical real estate to a separate real estate investment trust — sometimes one affiliated with the same ownership group — and then lease it back, converting what was an owned asset into an ongoing operating expense. The fund captures the immediate liquidity from the sale; the facility is left with a rent obligation that further constricts its operating budget. When the facility eventually struggles financially, the investors who structured the deal are often legally insulated from liability through a web of holding companies, management agreements, and shell entities that make accountability nearly impossible to trace.

A 2021 Senate investigation led by then-Finance Committee Chairman Ron Wyden documented this opacity in detail, finding that the corporate structures of private equity-owned nursing home chains were so deliberately complex that regulators could not easily identify who was ultimately responsible for care quality or financial decisions.

The Human Ledger

The people most directly harmed by this model are, by definition, among the most vulnerable in American society. The roughly 1.3 million Americans who reside in nursing facilities at any given time are disproportionately low-income — more than 60 percent of nursing home costs are covered by Medicaid, the program for the poor and the near-poor — elderly, and often cognitively or physically unable to advocate for themselves or relocate to alternative facilities. Their families frequently lack the resources, proximity, or legal knowledge to challenge care deficiencies effectively.

The racial dimension of nursing home quality is also stark. A 2020 study in Health Affairs found that Black residents were significantly more likely to be placed in lower-quality nursing facilities than white residents, even after controlling for geography and income. Private equity-owned facilities, which cluster in markets where real estate values and acquisition prices are most favorable to financial engineering, are not randomly distributed across the care quality spectrum.

For Medicaid-dependent residents — the majority — there is no market exit. They cannot take their business elsewhere when care deteriorates, because the alternatives are often no better, unavailable, or inaccessible without transportation and family support. The market's self-correcting mechanism, on which deregulatory ideology depends, does not function when the consumer is bedridden and the product is the only one in a fifty-mile radius.

The Industry's Defense — and Its Contradictions

The private equity industry and nursing home trade associations argue that investment capital has modernized facilities, improved technology, and brought management expertise to a sector that was chronically underfunded by Medicaid reimbursement rates. There is a grain of truth here: Medicaid reimbursement for long-term care has been inadequate in many states for decades, and some independent operators were poorly managed before private equity arrival.

But this argument contains a fundamental contradiction. If the problem is inadequate public reimbursement, the solution is higher Medicaid rates — not leveraged buyouts that extract capital from the same underfunded system while adding debt service costs and management fees that reduce the dollars available for direct care. The private equity model does not solve the underfunding problem; it monetizes it, capturing whatever margin exists while externalizing the human cost onto residents, families, and ultimately taxpayers through emergency Medicaid expenditures and regulatory enforcement costs.

The JAMA mortality data, the Senate investigation findings, and the COVID death toll in private equity facilities are not consistent with a story of improved management. They are consistent with a story of financial extraction that outpaced any operational improvements the model may have brought.

What Accountability and Reform Require

The Biden administration took meaningful steps toward addressing this crisis. In 2023, the Centers for Medicare and Medicaid Services finalized a rule establishing minimum staffing standards for nursing homes receiving federal funding — a long-overdue baseline requiring at least 0.55 hours of registered nurse care and 2.45 hours of nurse aide care per resident per day. Industry groups immediately challenged the rule in court, and its implementation timeline remains contested.

The staffing rule is necessary but not sufficient. Genuine reform requires: mandatory public disclosure of nursing home ownership structures, including all holding companies and real estate entities; restrictions on sale-leaseback transactions that strip facility assets; expanded CMS authority to hold ultimate beneficial owners — not just operating entities — accountable for care deficiencies; and enhanced civil penalties that are large enough to actually deter financial misconduct rather than function as a cost of doing business.

Legislatively, the Nursing Home Improvement and Accountability Act has been introduced in Congress with provisions addressing ownership transparency and staffing mandates. Like most healthcare accountability legislation, it has struggled to advance against the lobbying weight of the long-term care industry.

The financialization of elder care is not an isolated pathology. It is a preview of what happens when the logic of asset extraction is applied to services that vulnerable people cannot refuse and markets cannot adequately price. Nursing homes today; home health agencies tomorrow; hospice care the day after that. The pattern is consistent, the victims are predictable, and the regulatory response has been, until very recently, dangerously slow.

A society that warehouses its elders in facilities engineered for investor returns has made a choice about what human dignity is worth — and the answer, right now, is not enough.